BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3196509)

  • 1. Easy production of sterile, pyrogen-free dialysate.
    Erley CM; von Herrath D; Hartenstein-Koch K; Kutschera D; Amir-Moazami B; Schaefer K
    ASAIO Trans; 1988; 34(3):205-7. PubMed ID: 3196509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
    Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
    BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammation in hemodialysis: the role of contaminated dialysate.
    Lonnemann G
    Blood Purif; 2000; 18(3):214-23. PubMed ID: 10859424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment.
    Bambauer R; Meyer S; Jung H; Goehl H; Nystrand R
    ASAIO Trans; 1990; 36(3):M317-20. PubMed ID: 2252688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis.
    Port FK; VanDeKerkhove KM; Kunkel SL; Kluger MJ
    Am J Kidney Dis; 1987 Aug; 10(2):118-22. PubMed ID: 3496789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with a new hemodiafiltration (HDF) system.
    Rindi P; Pilone N; Riccò V; Cioni L
    ASAIO Trans; 1988; 34(3):765-8. PubMed ID: 3196595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo studies of dialysis-related endotoxemia and bacteremia.
    Bernick JJ; Port FK; Favero MS
    Nephron; 1981; 27(6):307-12. PubMed ID: 7266719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma.
    Geremia I; Bansal R; Stamatialis D
    Acta Biomater; 2019 May; 90():100-111. PubMed ID: 30953798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Atti M
    ASAIO J; 1992; 38(1):52-4. PubMed ID: 1313318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
    Lonnemann G; Sereni L; Lemke HD; Tetta C
    Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of endotoxins in high-flux dialysis.
    Smollich BP; Falkenhagen D; Schneidewind J; Mitzner S; Klinkmann H
    Nephrol Dial Transplant; 1991; 6 Suppl 3():83-5. PubMed ID: 1775273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the JMS fully automated dialysis machine.
    Tsuchiya S; Moriishi M; Takahashi N; Watanabe H; Kawanishi H; Kim ST; Masaoka K
    ASAIO J; 2003; 49(5):547-53. PubMed ID: 14524562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrogen retention by the polyamide membranes.
    Lonnemann G; Mahiout A; Schindler R; Colton CK
    Contrib Nephrol; 1992; 96():47-63. PubMed ID: 1740050
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin.
    Gordon SM; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Favero MS; Jarvis WR
    J Am Soc Nephrol; 1992 Mar; 2(9):1436-44. PubMed ID: 1627766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysate bacteriological quality and the permeability of dialyzer membranes to pyrogens.
    Lonnemann G
    Kidney Int Suppl; 1993 Jun; 41():S195-200. PubMed ID: 8320919
    [No Abstract]   [Full Text] [Related]  

  • 18. [High-efficiency membranes and the dialysis solution].
    Agliata S; Airoldi G; Baroni A; Boschetti M; Schweiger K; Fortina F; Ragazzoni E; Cavagnino A
    Minerva Urol Nefrol; 1990; 42(1):39-42. PubMed ID: 2389221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin.
    Pegues DA; Oettinger CW; Bland LA; Oliver JC; Arduino MJ; Aguero SM; McAllister SK; Gordon SM; Favero MS; Jarvis WR
    J Am Soc Nephrol; 1992 Oct; 3(4):1002-7. PubMed ID: 1450362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.